Information Provided By:
Fly News Breaks for August 6, 2019
Aug 6, 2019 | 07:16 EDT
SunTrust analyst Sandy Draper raised his price target on Teladoc to $80 and kept his Buy rating, saying he sees over 20% organic revenue growth in 2020. The analyst cites the management's positive comments about expanded relationship with United Health and negotiations with Medicare Advantage for more telemedicine services next year, with 75% increase in "all-in RFPs" being driven by the company's expanded platform offerings.
News For TDOC From the Last 2 Days
Sep 19, 2019 | 06:50 EDT
JPMorgan analyst Lisa Gill reiterates an Overweight rating on Teladoc and raised her price target for the shares to $83 from $82 after hosting investor meetings with management. The analyst says that while nothing materially new came out of the meetings, management's positive commentary and tone again served to reinforce her bullish view on the outlook. Gill continues to sees a "significant amount of runway" in the telehealth market. Teladoc is "very well positioned" as the only comprehensive virtual care delivery solution, says the analyst.